A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder

Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric urology 2012-06, Vol.8 (3), p.314-317
Hauptverfasser: Gor, Ronak A, Fuhrer, Jamie, Schober, Justine M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 317
container_issue 3
container_start_page 314
container_title Journal of pediatric urology
container_volume 8
creator Gor, Ronak A
Fuhrer, Jamie
Schober, Justine M
description Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N  = 319), 10 months in those with ADHD ( N  = 62), and 8 months in those with ASD ( N  = 10) ( P  = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.
doi_str_mv 10.1016/j.jpurol.2010.10.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1013921710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1477513110004870</els_id><sourcerecordid>1013921710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</originalsourceid><addsrcrecordid>eNqFUk2P1DAMrRCIXRb-AUI5cqBD0nYmzQVptVo-pJU4AOcoTVzGQ5uUJB3Un8c_w51Z9sCFUyL7-dl-z0XxUvCN4GL39rA5THMMw6bip9CGc_WouBStrMumVe1j-jdSlltRi4viWUoHzmvJK_W0uKgEBau6uSx-X7MIOYY0gc14BBa6BPFoMgZvBpby7BYWegZ-jpAwvWHOLBlHYMeADv13lpZxymGkjPGOyNIUfAKWAxvBoSWSvIdopoWhZ3aPg4vg2S_Me2ZyBr92Yg56tJjZfpkIu06CeWEOU4gO4onZzBnTyE6Dxnl8SD4vnvRmSPDi_r0qvr2__Xrzsbz7_OHTzfVdaRshc9lx0_dO7ZTcNrJRykHj2srI3rVtxyXvJN9uVWM7bitbS8t5s5NS1CQnb7dK1VfF6zPvFMPPGVLWIyYLw2A8hDlpMqVWlZCCE7Q5Qy0JmyL0eoo4mrgQaMXt9EGfzdOreWuUzKOyV_cd5o60eyj66xYB3p0BQHseEaJOFsFb0jmSKtoF_F-HfwnsgH416QcskA5hjuQ67aJTpbn-sh7Qej-Ckxyt5PUfNVfHVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1013921710</pqid></control><display><type>article</type><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</creator><creatorcontrib>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</creatorcontrib><description>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N  = 319), 10 months in those with ADHD ( N  = 62), and 8 months in those with ASD ( N  = 10) ( P  = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</description><identifier>ISSN: 1477-5131</identifier><identifier>EISSN: 1873-4898</identifier><identifier>DOI: 10.1016/j.jpurol.2010.10.009</identifier><identifier>PMID: 21131234</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anticholinergic ; Antidiuretic Agents - therapeutic use ; Asperger ; Attention Deficit and Disruptive Behavior Disorders - complications ; Autism ; Child ; Child Development Disorders, Pervasive - complications ; Cholinergic Antagonists - therapeutic use ; DDAVP ; Deamino Arginine Vasopressin - therapeutic use ; Desmopressin ; Enuresis ; Enuresis - complications ; Enuresis - drug therapy ; Enuresis - epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Oxybutynin ; Pediatrics ; Pennsylvania - epidemiology ; Pervasive developmental disorder ; Retrospective Studies ; Tolterodine ; Treatment Outcome ; Urination - drug effects ; Urination - physiology ; Urology ; Voiding dysfunction</subject><ispartof>Journal of pediatric urology, 2012-06, Vol.8 (3), p.314-317</ispartof><rights>Journal of Pediatric Urology Company</rights><rights>2010 Journal of Pediatric Urology Company</rights><rights>Copyright © 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</citedby><cites>FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpurol.2010.10.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21131234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gor, Ronak A</creatorcontrib><creatorcontrib>Fuhrer, Jamie</creatorcontrib><creatorcontrib>Schober, Justine M</creatorcontrib><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><title>Journal of pediatric urology</title><addtitle>J Pediatr Urol</addtitle><description>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N  = 319), 10 months in those with ADHD ( N  = 62), and 8 months in those with ASD ( N  = 10) ( P  = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</description><subject>Anticholinergic</subject><subject>Antidiuretic Agents - therapeutic use</subject><subject>Asperger</subject><subject>Attention Deficit and Disruptive Behavior Disorders - complications</subject><subject>Autism</subject><subject>Child</subject><subject>Child Development Disorders, Pervasive - complications</subject><subject>Cholinergic Antagonists - therapeutic use</subject><subject>DDAVP</subject><subject>Deamino Arginine Vasopressin - therapeutic use</subject><subject>Desmopressin</subject><subject>Enuresis</subject><subject>Enuresis - complications</subject><subject>Enuresis - drug therapy</subject><subject>Enuresis - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Oxybutynin</subject><subject>Pediatrics</subject><subject>Pennsylvania - epidemiology</subject><subject>Pervasive developmental disorder</subject><subject>Retrospective Studies</subject><subject>Tolterodine</subject><subject>Treatment Outcome</subject><subject>Urination - drug effects</subject><subject>Urination - physiology</subject><subject>Urology</subject><subject>Voiding dysfunction</subject><issn>1477-5131</issn><issn>1873-4898</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk2P1DAMrRCIXRb-AUI5cqBD0nYmzQVptVo-pJU4AOcoTVzGQ5uUJB3Un8c_w51Z9sCFUyL7-dl-z0XxUvCN4GL39rA5THMMw6bip9CGc_WouBStrMumVe1j-jdSlltRi4viWUoHzmvJK_W0uKgEBau6uSx-X7MIOYY0gc14BBa6BPFoMgZvBpby7BYWegZ-jpAwvWHOLBlHYMeADv13lpZxymGkjPGOyNIUfAKWAxvBoSWSvIdopoWhZ3aPg4vg2S_Me2ZyBr92Yg56tJjZfpkIu06CeWEOU4gO4onZzBnTyE6Dxnl8SD4vnvRmSPDi_r0qvr2__Xrzsbz7_OHTzfVdaRshc9lx0_dO7ZTcNrJRykHj2srI3rVtxyXvJN9uVWM7bitbS8t5s5NS1CQnb7dK1VfF6zPvFMPPGVLWIyYLw2A8hDlpMqVWlZCCE7Q5Qy0JmyL0eoo4mrgQaMXt9EGfzdOreWuUzKOyV_cd5o60eyj66xYB3p0BQHseEaJOFsFb0jmSKtoF_F-HfwnsgH416QcskA5hjuQ67aJTpbn-sh7Qej-Ckxyt5PUfNVfHVg</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Gor, Ronak A</creator><creator>Fuhrer, Jamie</creator><creator>Schober, Justine M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</title><author>Gor, Ronak A ; Fuhrer, Jamie ; Schober, Justine M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-b0affd9697547499de4d82a7fd88b070b705594cb0c2c37c00467713873085993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anticholinergic</topic><topic>Antidiuretic Agents - therapeutic use</topic><topic>Asperger</topic><topic>Attention Deficit and Disruptive Behavior Disorders - complications</topic><topic>Autism</topic><topic>Child</topic><topic>Child Development Disorders, Pervasive - complications</topic><topic>Cholinergic Antagonists - therapeutic use</topic><topic>DDAVP</topic><topic>Deamino Arginine Vasopressin - therapeutic use</topic><topic>Desmopressin</topic><topic>Enuresis</topic><topic>Enuresis - complications</topic><topic>Enuresis - drug therapy</topic><topic>Enuresis - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Oxybutynin</topic><topic>Pediatrics</topic><topic>Pennsylvania - epidemiology</topic><topic>Pervasive developmental disorder</topic><topic>Retrospective Studies</topic><topic>Tolterodine</topic><topic>Treatment Outcome</topic><topic>Urination - drug effects</topic><topic>Urination - physiology</topic><topic>Urology</topic><topic>Voiding dysfunction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gor, Ronak A</creatorcontrib><creatorcontrib>Fuhrer, Jamie</creatorcontrib><creatorcontrib>Schober, Justine M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gor, Ronak A</au><au>Fuhrer, Jamie</au><au>Schober, Justine M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder</atitle><jtitle>Journal of pediatric urology</jtitle><addtitle>J Pediatr Urol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>8</volume><issue>3</issue><spage>314</spage><epage>317</epage><pages>314-317</pages><issn>1477-5131</issn><eissn>1873-4898</eissn><abstract>Abstract Introduction Children with attention deficit hyperactivity disorder (ADHD) show an increased prevalence of enuresis and other daytime voiding symptoms (DVS). There is also some evidence toward an increased prevalence of enuresis among children with autism spectrum disorder (ASD), but with no data available with respect to DVS or response to medical treatment. The aim of this study was to assess enuresis and DVS, along with treatment outcomes, in children with ASD, to aid urological management. Methods A retrospective observational study on the incidence of enuresis and other DVS in 671 children with/without ADHD/ASD was performed. Symptomatic improvement ≥50% was required to be considered positive. Complete resolution of symptoms for 3 months after cessation of treatment was considered cure. Results Symptomatic improvement with desmopressin or anticholinergic treatment was seen in 76% of patients without ADHD/ASD, 85% of patients with ADHD, and 100% of patients with ASD. Cure was seen in 61% of patients without ADHD/ASD, 48% of patients with ADHD, and 50% patients with ASD. Mean time to cure was 9 months in those without ADHD/ASD ( N  = 319), 10 months in those with ADHD ( N  = 62), and 8 months in those with ASD ( N  = 10) ( P  = 0.69). Conclusion Despite the small sample size of patients with ASD, our data show a favorable trend toward efficacy of desmopressin and anticholinergic therapy in these children with enuresis and DVS.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>21131234</pmid><doi>10.1016/j.jpurol.2010.10.009</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1477-5131
ispartof Journal of pediatric urology, 2012-06, Vol.8 (3), p.314-317
issn 1477-5131
1873-4898
language eng
recordid cdi_proquest_miscellaneous_1013921710
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Anticholinergic
Antidiuretic Agents - therapeutic use
Asperger
Attention Deficit and Disruptive Behavior Disorders - complications
Autism
Child
Child Development Disorders, Pervasive - complications
Cholinergic Antagonists - therapeutic use
DDAVP
Deamino Arginine Vasopressin - therapeutic use
Desmopressin
Enuresis
Enuresis - complications
Enuresis - drug therapy
Enuresis - epidemiology
Female
Follow-Up Studies
Humans
Incidence
Male
Oxybutynin
Pediatrics
Pennsylvania - epidemiology
Pervasive developmental disorder
Retrospective Studies
Tolterodine
Treatment Outcome
Urination - drug effects
Urination - physiology
Urology
Voiding dysfunction
title A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20retrospective%20observational%20study%20of%20enuresis,%20daytime%20voiding%20symptoms,%20and%20response%20to%20medical%20therapy%20in%20children%20with%20attention%20deficit%20hyperactivity%20disorder%20and%20autism%20spectrum%20disorder&rft.jtitle=Journal%20of%20pediatric%20urology&rft.au=Gor,%20Ronak%20A&rft.date=2012-06-01&rft.volume=8&rft.issue=3&rft.spage=314&rft.epage=317&rft.pages=314-317&rft.issn=1477-5131&rft.eissn=1873-4898&rft_id=info:doi/10.1016/j.jpurol.2010.10.009&rft_dat=%3Cproquest_cross%3E1013921710%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1013921710&rft_id=info:pmid/21131234&rft_els_id=1_s2_0_S1477513110004870&rfr_iscdi=true